Literature DB >> 20045728

Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example.

Chiun-Sheng Huang1, Ching-Hung Lin, Yen-Shen Lu, Chen-Yang Shen.   

Abstract

Breast carcinoma is one of the most common cancers in women and is known to arise from a multifactorial process, the effect of reproductive risk factors strongly supporting a hormonal role in its etiology. Breast cancer in Asia is characterized by a lower incidence than in Western populations, but is still the leading type of cancer in Asian women, and a significant increasing tread indicates that it is an issue of particular public health importance. Asian breast cancer is characterized by early tumor onset, showing a relatively younger median age at diagnosis. Recently, scientists began to explore the tumorigenic mechanisms underlying breast cancer formation at the molecular level. Both a candidate-gene approach and genome-wide association studies have yielded crucial insights into breast cancer susceptibility genes initiating breast tumorigenesis. As expected, ethnic/racial variation in the genotypic frequency of these genes results in differences in breast cancer incidence in different populations. Furthermore, the question of how important these genes are in Asian breast cancer remains to be explored. It has been demonstrated that gene expression profiles and gene sets are prognostic and predictive for patients with breast cancer. Originally, due to its early onset, it was speculated that Asian breast cancer would have a higher frequency of the basal-like subtype of breast cancer, a molecular subtype characterized by poor differentiation, resulting in a relatively poor progression; however, recent findings do not support this speculation. The frequency of the luminal-A subtype of breast cancer, characterized by estrogen receptor expression, is similar to that in breast cancer in Caucasian, supporting the usefulness of hormone-based therapy in Asian breast cancer. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20045728     DOI: 10.1016/j.jsbmb.2009.12.017

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  23 in total

1.  Acridone suppresses the proliferation of human breast cancer cells in vitro via ATP-binding cassette subfamily G member 2.

Authors:  Licheng Xu; Shuyan Li; Zhi Liang; Haixia Lin; Rongzhan Fu
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

2.  Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian Women.

Authors:  Neil M Iyengar; I-Chun Chen; Xi K Zhou; Dilip D Giri; Domenick J Falcone; Lisle A Winston; Hanhan Wang; Samantha Williams; Yen-Shen Lu; Tsu-Hsin Hsueh; Ann-Lii Cheng; Clifford A Hudis; Ching-Hung Lin; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2017-12-08

3.  Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients.

Authors:  Yi-Ling Chen; Kuo-Ting Lee; Chih-Yang Wang; Che-Hung Shen; Sheau-Chiann Chen; Wei-Pang Chung; Ya-Ting Hsu; Yao-Lung Kuo; Pai-Sheng Chen; Chun Hei Antonio Cheung; Chih-Peng Chang; Meng-Ru Shen; Hui-Ping Hsu
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

4.  Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.

Authors:  Ching-Hung Lin; Po-Ya Chuang; Chun-Ju Chiang; Yen-Shen Lu; Ann-Lii Cheng; Wen-Hung Kuo; Chiun-Sheng Huang; Mei-Shu Lai; San-Lin You; Chao-Hsiun Tang
Journal:  Oncologist       Date:  2014-05-07

Review 5.  Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.

Authors:  Tingyu Wang; Yitian Zhou; Guosheng Cao
Journal:  Eur J Clin Pharmacol       Date:  2021-01-29       Impact factor: 2.953

6.  Postmenopausal breast cancer in Iran; risk factors and their population attributable fractions.

Authors:  Reza Ghiasvand; Shahram Bahmanyar; Kazem Zendehdel; Sedigheh Tahmasebi; Abdolrasoul Talei; Hans-Olov Adami; Sven Cnattingius
Journal:  BMC Cancer       Date:  2012-09-19       Impact factor: 4.430

7.  Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study.

Authors:  Fu-Hsiung Su; Shih-Ni Chang; Pei-Chun Chen; Fung-Chang Sung; Chien-Tien Su; Chih-Ching Yeh
Journal:  BMC Cancer       Date:  2011-11-24       Impact factor: 4.430

8.  The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study.

Authors:  Mei-Chi Hsu; Kuo-Ting Lee; Wei-Chiang Hsiao; Chih-Hsing Wu; Hung-Yu Sun; I-Ling Lin; Kung-Chia Young
Journal:  BMC Cancer       Date:  2013-07-05       Impact factor: 4.430

Review 9.  Obesity and Energy Balance Considerations in Triple-Negative Breast Cancer.

Authors:  Elizabeth R Berger; Neil M Iyengar
Journal:  Cancer J       Date:  2021 Jan-Feb 01       Impact factor: 3.360

10.  Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells.

Authors:  Chun-Yu Liu; Man-Hsin Hung; Duen-Shian Wang; Pei-Yi Chu; Jung-Chen Su; Tsung-Han Teng; Chun-Teng Huang; Ting-Ting Chao; Cheng-Yi Wang; Chung-Wai Shiau; Ling-Ming Tseng; Kuen-Feng Chen
Journal:  Breast Cancer Res       Date:  2014-09-17       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.